IRD
Opus Genetics, Inc. Common Stock
26 hedge funds and large institutions have $2.62M invested in Opus Genetics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
-2
Holders Change %
-7.14%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
9
Reduced
5
Closed
6
Calls
$15K
Puts
–
Net Calls
+$15K
Net Calls Change
-$41K
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$244K |
2 |
Northern Trust
Chicago,
Illinois
|
+$44.5K |
3 |
UBS Group
Zurich,
Switzerland
|
+$9.55K |
4 |
NWM
Northwest Wealth Management
Spencer,
Iowa
|
+$6K |
5 |
![]()
Group One Trading
Chicago,
Illinois
|
+$5.93K |